MedPath

The seroepidemiology of mumps in a highly vaccinated population of university students in the Netherlands

Completed
Conditions
mumps
10047438
Registration Number
NL-OMON34179
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
250
Inclusion Criteria

Medical students (2nd, 3rd, 4th year) from the LUMC.

Exclusion Criteria

No exclusion.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>In the first analysis, the primary study parameter will be the measured mumps<br /><br>titers in the paired serumsamples in the group that has claimed to have had a<br /><br>clinical mumps infection. As a controle on the natural behaviour of MMR<br /><br>antibody titers after several years, also measles and rubella titers will be<br /><br>measured in the same multiplex ELISA at the RIVM.<br /><br><br /><br>In a second analysis, the occurence of clinical mumps (based on the<br /><br>questionnaire) and subclinical mumps (based on a similar titerrise as in the<br /><br>group with clinical mumps) is the primary study parameter. In this case, the<br /><br>effect of the mumpstiters on the occurence of mumps will be investigated.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>As secondary parameters the relation between the number of MMR vaccines (0, 1<br /><br>of 2) will be related to the mumpstiters in the first serum sample.</p><br>
© Copyright 2025. All Rights Reserved by MedPath